These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17825570)

  • 1. Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.
    Murugaiah AM; Wallinder C; Mahalingam AK; Wu X; Wan Y; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
    Bioorg Med Chem; 2007 Nov; 15(22):7166-83. PubMed ID: 17825570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
    Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
    J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
    Mahalingam AK; Wan Y; Murugaiah AM; Wallinder C; Wu X; Plouffe B; Botros M; Nyberg F; Hallberg A; Gallo-Payet N; Alterman M
    Bioorg Med Chem; 2010 Jun; 18(12):4570-90. PubMed ID: 20493713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
    Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
    J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
    Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
    J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
    Wallinder C; Botros M; Rosenström U; Guimond MO; Beaudry H; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
    Bioorg Med Chem; 2008 Jul; 16(14):6841-9. PubMed ID: 18599297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
    Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
    J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
    Murugaiah AM; Wu X; Wallinder C; Mahalingam AK; Wan Y; Sköld C; Botros M; Guimond MO; Joshi A; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
    J Med Chem; 2012 Mar; 55(5):2265-78. PubMed ID: 22248302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of selective non-peptide angiotensin II type 2 receptor agonists.
    Alterman M
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):57-66. PubMed ID: 19880657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
    Wan Y; Wallinder C; Johansson B; Holm M; Mahalingam AK; Wu X; Botros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Hallberg A; Alterman M
    J Med Chem; 2004 Mar; 47(6):1536-46. PubMed ID: 14998339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists.
    Madsen C; Jensen AA; Liljefors T; Kristiansen U; Nielsen B; Hansen CP; Larsen M; Ebert B; Bang-Andersen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2007 Aug; 50(17):4147-61. PubMed ID: 17655213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.
    Georgsson J; Rosenström U; Wallinder C; Beaudry H; Plouffe B; Lindeberg G; Botros M; Nyberg F; Karlén A; Gallo-Payet N; Hallberg A
    Bioorg Med Chem; 2006 Sep; 14(17):5963-72. PubMed ID: 16753301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenosartans: novel selenophene analogues of milfasartan and eprosartan.
    Grange RL; Ziogas J; North AJ; Angus JA; Schiesser CH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1241-4. PubMed ID: 18191398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
    Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2006 Oct; 49(20):6133-7. PubMed ID: 17004728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
    van Esch JH; Oosterveer CR; Batenburg WW; van Veghel R; Jan Danser AH
    Eur J Pharmacol; 2008 Jul; 588(2-3):286-93. PubMed ID: 18511032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor.
    Sköld C; Nikiforovich G; Karlén A
    J Mol Graph Model; 2008 Feb; 26(6):991-1003. PubMed ID: 17936050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.